Keywords: strong, ph, data, roche, hcv, drug, r1626

Strong Ph I data for Roche's HCV drug R1626

Article | 06 November 2006

Print This

Swiss drug major Roche says that new clinical data on its investigational hepatitis C polymerase inhibitor R1626 shows viral reductions ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in